Verona Pharma plc (VRNA) Debt by Year
Verona Pharma plc carried $120.3M in long-term debt against $399.8M in cash and equivalents at the end of fiscal year 2024. This represents an increase of 148.8% from the prior fiscal year. The table below carries 6 fiscal years, from 2019 to 2024, and the quarters Verona Pharma plc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
VRNA Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
VRNA Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2510-Q | Q1'2510-Q | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K | Q3'2210-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $242.4M+102.6% | $241.7M+398.0% | $120.3M+148.8% | $120.0M+502.9% | $119.7M+502.7% | $48.5M+145.1% | $48.4M+395.2% | $19.9M+295.3% | $19.9M+298.7% | $19.8M+302.0% | $9.8M+100.4% | $5.0M+4.4% |
| Cash & Equivalents | $438.0M+8.3% | $401.4M+57.5% | $399.8M+47.1% | $336.0M+30.6% | $404.6M+49.4% | $254.9M-12.5% | $271.8M+19.3% | $257.4M+11.1% | $270.7M+142.8% | $291.4M+119.5% | $227.8M+53.5% | $231.7M+39.1% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More Verona Pharma plc financials
Frequently Asked Questions
What was Verona Pharma plc's long-term debt in fiscal year 2024?
Verona Pharma plc carried $120.3M in long-term debt against $399.8M in cash and equivalents at the end of fiscal year 2024.
How fast is Verona Pharma plc's long-term debt growing?
Verona Pharma plc (VRNA) long-term debt rose by 148.8% year over year, from $48.4M to $120.3M in fiscal year 2024.
How has Verona Pharma plc's long-term debt changed over the years?
Across the 6 fiscal years this page covers, Verona Pharma plc (VRNA) long-term debt went from $0 in fiscal year 2019 to $120.3M in fiscal year 2024.
What was Verona Pharma plc's long-term debt in the most recent quarter?
Verona Pharma plc (VRNA) reported $242.4M in long-term debt in Q2 2025. This represents an increase of 102.6% from the same quarter a year earlier.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Verona Pharma plc (VRNA) reported on that line in every period on record.